We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Randomised trial assessed efficacy and immunogenicity of the nasal BPZE1 vaccine in adults, suggesting it may enhance pertussis protection.
ILiAD Biotechnologies.
No takes yet. Share an insight, caveat, or question.
Raud et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: